Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Enviga pays to settle 27 claims

This article was originally published in The Tan Sheet

Executive Summary

Coca-Cola and Nestle settle with 26 states and the District of Columbia to resolve allegations that Enviga green tea's "implied weight-loss claims were scientifically weightless," Connecticut Attorney General Richard Blumenthal says. Enviga labels, which previously said consuming three cans a day burned an extra 60 to 100 calories, now must clearly state that calorie elimination and weight loss require proper diet and exercise, according to the Feb. 26 release. Coca-Cola and Nestle will pay $650,000. In their Beverage Partnership Worldwide joint venture, the firms marketed Enviga as a weight-loss product based on a three-day study with 31 healthy 18- to 35-year-olds. The Center for Science in the Public Interest filed a complaint with the Federal Trade Commission about linking claims to the small study (1"The Tan Sheet" May 28, 2007, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel